Abstracts tagged "radiography and systemic sclerosis"

Abstract Number: 679 • 2013 ACR/ARHP Annual Meeting
Validation Of a Novel Radiographic Scoring System For Calcinosis Affecting The Hands Of Patients With Systemic Sclerosis
Lorinda Chung¹, Antonia Maria Valenzuela Vergara², David Fiorentino³, Kate Stevens², Shufeng Li⁴, Jonathan Harris⁵, Charles E. Hutchinson⁶, Shervin Assassi⁷, Lorenzo Beretta⁸, Santhanam Lakshminarayanan⁹, Tatiana Rodriguez Reyna¹⁰, Christopher P. Denton¹¹, Rebecca G. Taillefer¹², Solene Tatibouet¹³, Ariane Herrick¹⁴ and Murray Baron¹⁵, ¹Rheumatology, Stanford Univ Medical Center, Palo Alto, CA, ²Stanford University School of Medicine, Stanford, CA, ³Dermatology, Stanford University School of Medicine, Redwood City, CA, ⁴Dermatology, Stanford University School of Medicine, Palo Alto, CA, ⁵Salford Royal Hospital, Manchester, United Kingdom, ⁶Warwick Medical School, University of Warwick, Coventry, United Kingdom, ⁷Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ⁸Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, ⁹Dept of Med/Div Rheum Diseases, University of Connecticut School of Medicine, Farmington, CT, ¹⁰Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico, ¹¹Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom, ¹²University of Montreal, Montreal, QC, Canada, ¹³Jewish General Hospital, McGill University, Montreal, QC, Canada, ¹⁴Musculoskeletal Research Group, University of Manchester, Salford, United Kingdom, ¹⁵Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada
Background/Purpose: Calcinosis affects approximately 25% of patients with systemic sclerosis (SSc) and is associated with substantial morbidity. There are currently no validated outcome measures…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].